Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial

Peer Review reports

Original Submission
13 Jun 2018	Submitted	Original manuscript
10 Oct 2018	Reviewed	Reviewer Report - Dietrich Haubenberger
23 Nov 2018	Author responded	Author comments - Elena Gross
Resubmission - Version 2
23 Nov 2018	Submitted	Manuscript version 2
Publishing
9 Dec 2018	Editorially accepted
17 Jan 2019	Article published	10.1186/s13063-018-3120-7

Back to article page